Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Diabetics Doing Things Podcast

Episode 327 - Farhaneh Ahmadi - CEO & Co-Founder of Eddii

18 Jul 2025

Description

In this episode of the Diabetes Innovators Series, Rob interviews Farhaneh Ahmadi, CEO and co-founder of Eddii, a virtual care solution for diabetes management. They discuss the evolution of Eddie from a daily management app to a comprehensive virtual clinic, addressing barriers to endocrinology care, the importance of insurance coverage, and the integration of technology for better patient outcomes. Farhan shares his personal journey with diabetes and how it inspired the creation of Eddie, emphasizing the need for accessible and patient-centric care. The conversation also touches on future directions for Eddie, including expanding services and enhancing mental health support. Chapters 00:00 Embracing the Cringe: Personal Reflections on Self-Image 01:00 Introducing Eddie: A Comprehensive Virtual Care Solution 02:17 The Evolution of Eddie: From App to Virtual Clinic 03:25 Breaking Barriers: Access to Endocrinology Care 05:18 Insurance and Accessibility: Making Care Affordable 07:38 Empowering Providers: A New Model for Endocrinology 08:56 Patient-Centric Care: Customizing the Experience 10:19 The Inspiration Behind Eddie: A Personal Journey 12:34 Integrating Technology: Real-Time Data for Better Management 13:58 Unique Features: Glucose Alert Calls and Support 15:44 Future Directions: AI and Expanding Care Options 17:54 Raising Awareness: The Need for Accessible Endocrinology 20:13 Navigating Care: Understanding Options and Costs 21:35 Leadership Insights: Books and Personal Growth Resources: Eddie Farhaneh Ahmadi LinkedIn

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.